ArticleSpringerPlus2016

Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients.

Taru Hallinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.